Fact CheckerSign in

NCT07474051Enrolling by invitationPhase 1

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

Persistence Evaluation and Response Study for Immunotherapy Safety Tracking of Participants Who Receive an AvenCell CAR-T Cell Therapy

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.

Status (registry)
Enrolling by invitation
Phase (registry)
Phase 1
Study type
Observational
Enrollment
178 (estimated)
First submitted
11 Mar 2026
Start date
29 Jan 2026
Primary completion date
30 Nov 2040
Lead sponsor
AvenCell Therapeutics, Inc.
NCT number
NCT07474051
EU CT number
2025-521717-67-00

What you commit to

  • Study type: Observational · Phase 1
  • Planned participants: 178
  • From 29 Jan 2026 to the primary completion date, 30 Nov 2040
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participant is unable to provide written informed consent.
  • Participant is unable to comply with study requirements in the eyes of the Investigator.

Who the study is looking for

  • Participant who received an AVC-CAR-T cell therapy within an AVC-sponsored clinical trial.
  • Participant signed written informed consent for the AVC-PERSIST study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Charite Universitaetsmedizin Berlin KöR
Coordinator of this site? Confirm its status
BerlinGermanyRecruiting
Technische Universitaet Dresden
Coordinator of this site? Confirm its status
DresdenGermanyRecruiting
Philipps-Universitaet Marburg
Coordinator of this site? Confirm its status
MarburgGermanyRecruiting
LMU Klinikum Muenchen AöR
Coordinator of this site? Confirm its status
MunichGermanyRecruiting
Universitaetsklinikum Ulm AoR
Coordinator of this site? Confirm its status
UlmGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.